Cantor Fitzgerald restated their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a ...

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...

Poseida Therapeutics Inc (PSTX) stock saw a decline, ending the day at $9.4 which represents a decrease of $-0.20 or -2.08% from the prior close of $9.6. The stock opened at $9.54 and touched a low of ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $14.99 which represents a slight increase of $0.22 or 1.49% from the prior close of $14.77. The stock opened at $14.9 ...

We recently published a list of 10 Buzzing AI Stocks on Latest Analyst Ratings and News. In this article, we are going to ...

On that date, Aquila announced separate agreements with New York Life and Cantor Fitzgerald to sell its investment advisory business. Pending the expected completion of those transactions in July ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Brandon, 26, has been with Cantor Fitzgerald, L.P., involved in managing strategy and overseeing special projects. His previous roles included equities trader at Cantor Fitzgerald & Co. and credit ...

We recently published an article titled Market Slump Drags Down Share Prices of These 15 Companies. In this article, we are ...

Weakness in Cantor Fitzgerald High Income A's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative. Our research team assigns Negative ratings to ...

Brandon, 26, has been with Cantor Fitzgerald, L.P., involved in managing strategy and overseeing special projects. His previous roles included equities trader at Cantor Fitzgerald & Co. and credit ...